Search Results
Results found for "Nobel Prize"
- Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
Heptares sign agreement to advance cancer immunotherapy candidate into clinical trials "HTL0039732 is a novel
- 📰 GPCR Weekly News - January 2 to 8, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
GPCR University 🎥 Recorded GPCR Courses and Symposia / Summit 💲 Special Pricing on GPCR courses Receptor Type 2 (NTS2) Opioid-Free Analgesics GPCRs in Cardiology, Endocrinology, and Taste Elucidating novel
- Synthesis and characterization of an orally bioavailable small molecule agonist of the apelin recept
Previously, we had identified a novel pyrazole-based agonist 1 ((S)-N-(1-(cyclobutylamino)-1-oxo-5-(piperidin
- Molecular basis for ligand modulation of the cannabinoid CB 1 receptor
These advances have paved the way for development of novel ligands for different therapeutic applications
- Dr. GPCR University registration is now open! Secure your spot now!
Downstream Proteins Indicates Biased Signal Transduction Pathways Activation of a GPCR, ORL1 receptor: A novel cells Industry News Confo Therapeutics Announces EUR 60M Series B Financing to Advance a Pipeline of Novel
- 📰 GPCR Weekly News
Phenotypic screen identifies the natural product silymarin as a novel anti-inflammatory analgesic. Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- 📰 GPCR Weekly News, June 24 to 30, 2024
Let’s dive into the Classified GPCR News from June 24th to 30th, 2024 Adhesion GPCRs Novel Isoforms of Disease-Associated GαS Variants Characterized by an Integrative Biophysical Approach Redox-modulated SNX25 as a novel
- High hedgehog signaling is transduced by a multikinase-dependent switch controlling the...
these results link the morphogenetic effects of HH to the apico-basal distribution of SMO and provide a novel
- Reversible Photocontrol of Dopaminergic Transmission in Wild-Type Animals
Here, we introduce azodopa, a novel photoswitchable ligand that enables reversible spatiotemporal control
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- Adenosine receptor signalling in Alzheimer's disease
available medicines targeting these receptors approved for treating dementia, we provide insights into some novel
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
Become a Premium Member to access both courses at a reduced price. Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45 Adenosine A2a receptor: novel
- Crinetics Pharmaceuticals Expands Executive Team With Appointment Of James Hassard As Chief ...
clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel
- Exscientia is 10 years old this July!
Founded as a spinout from the University of Dundee on 20 July 2012, Exscientia pioneered the design of novel
- PLC-IP3-ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal...
ORAI pathway participates in the activation of the MRGPRB2 receptor in mouse peritoneal mast cells "A novel
- Pharmacology at Your Fingertips: Terry’s Corner Launches
must-read chemokine and PTH1R papers, and new momentum across biotech—from Superluminal to Neurocrine to novel
- Nanobodies as Probes and Modulators of Cardiovascular G Protein-Coupled Receptors
As a result, there is an ongoing need to develop novel approaches to monitor and to modulate GPCR activation
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled receptor (GPCR) structures reveal novel
- Trevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team
(Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
selectivity/biased signaling has led to the discovery of biased compounds as both research tools and novel
- 📰 GPCR Weekly News - January 9 to 15, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential. Investigation Of The Role Of The Formyl Peptide Receptor 2 In Diabetic Retinopathy PhD Opportunity - Novel
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
Oliver Hartley, Orion’s Vice-President Drug Discovery, will present Orion’s novel technology for targeting
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
clinical stage company unlocking the therapeutic potential of G Protein-Coupled Receptors (GPCRs) with a novel
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
announced that its collaboration agreement with Indivior PLC (LON: INDV) for discovering and developing novel
- GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for...
We synthesized and characterized a novel A2AAR antagonist, 2 (LJ-4517), with Ki = 18.3 nM.
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- Helix 8 in chemotactic receptors of the complement system
Orthosteric and allosteric antagonists of C5aR1 are a novel strategy for anti-inflammatory therapies.
- Profiling Immune Cell and Platelet Transcriptomes
hematopoietic stem cells, suggesting a potential role in regulating red blood cell production and offering a novel






